AavantiBio
is a Massachusetts-based biotechnology company that develops gene therapies for the treatment of cardiac and central nervous system dysfunctions... Read moreAavantiBio
is a Massachusetts-based biotechnology company that develops gene therapies for the treatment of cardiac and central nervous system dysfunctions... Read more
News
Dec 05, 2022
Citybizlist
AavantiBio: Solid Biosciences Acquires AavantiBio
Oct 04, 2022
Pharmaphorum
AavantiBio: Solid Biosciences acquires AavantiBio, conducts $75 million private placement
Sep 30, 2022
BioPharma Dive
AavantiBio: Solid Bio yields to Sarepta on Duchenne with plans for merger, R&D shakeup
Feb 09, 2022
Citybizlist
AavantiBio: AavantiBio Announces Formation of Scientific Advisory Board
Feb 09, 2022
Business Wire
Press Release: AavantiBio : AavantiBio Announces Formation of Scientific Advisory Board
Jan 04, 2022
MarketScreener
AavantiBio: AavantiBio to Present at the 40th Annual J.P. Morgan Healthcare Conference
Oct 12, 2021
HPC Wire
AavantiBio: UF's HiPerGator 3.0 to Power AavantiBio's Next Generation Gene Therapy Capsid Research
Jul 26, 2021
Contract Pharma
AavantiBio: AavantiBio, Aldevron Form Gene Therapy Partnership
Jun 03, 2021
Endpoints News
AavantiBio: AavantiBio lands manufacturing partner in Friedreich's Ataxia program; NC Research Triangle lands another CDMO
Jun 03, 2021
BioSpace
AavantiBio: AavantiBio and Resilience Announce Strategic Collaboration for Gene Therapy Development and Manufacturing
